Performance: The design of the technical solution in on the track. Now we are improving the reliability of the actuation mechanism.
Time: All milestones have been achieved on schedule. We are on track for a commercial release in Q4 2026.
Funding: We have successfully validated our solution in a resource-limited setting and with the community help, we bootstrapped our company. We require a seed investment of $52,000 to develop certified prototypes, perform an official clinical trial, and to produce our first batch.
Economics and Sustainability Unit:
Total Addressable Market (TAM): Globally around more than 30 million people are not able to get prosthetic treatment.
Serviceable Obtainable Market (SOM): Potential users for partner network will be homeless people in U.S. (native and immigrants also). First launch will be the partnership with NGO’s based abroad. Initial 500,000+ users can be obtained.
Value Proposition: At a price point of $500, the device is accessible not only to individuals but also to charitable organizations capable of purchasing it in quantity, thereby multiplying the impact.
SHOCKING METRIC:
Current Estimated Cost-per-Unit: ~$250
Sale Price: $500.00.
Unit Gross Margin: ~50%
Path to Profitability: The revenue will be reinvested to improvement on production automation for lower unit price and better margin to fund the R&D for new model development and new market expansion. This self-sustaining cycle will further build the social impact.
Metrics of Impact:
Metric: People impacted (Devices distributed).
Secondary Metrics: Improved user quality of life, economic self-sufficiency and reduced reliance on caregivers.
Long-Term Goal: Minimize shipping costs and establish local employment opportunities in strategically important regions with manufacturing centers for initiating local economic progress.
